Opportunities for vein-to-vein datasets from a blood establishment perspective: Towards a 'Pan-European Transfusion Research InfrAstructure'.

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2026-08-18 DOI:10.1111/vox.70340
Sophie M T Wehrens, Mikko Arvas, Suzanne F Fustolo-Gunnink, Matea Vinković Vlah, Allison Waters, Christian Erikstrup, Louise Ørnskov Drechsler, Simon J Stanworth, Katja van den Hurk
{"title":"Opportunities for vein-to-vein datasets from a blood establishment perspective: Towards a 'Pan-European Transfusion Research InfrAstructure'.","authors":"Sophie M T Wehrens, Mikko Arvas, Suzanne F Fustolo-Gunnink, Matea Vinković Vlah, Allison Waters, Christian Erikstrup, Louise Ørnskov Drechsler, Simon J Stanworth, Katja van den Hurk","doi":"10.1111/vox.70340","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The 'Pan-European Transfusion Research InfrAstructure' (PETRA) project was established to advance the use of donor, blood product and patient datasets in Europe, aiming to benefit both patient and donor health. Here, the initial PETRA objective was to describe the landscape of existing donor and blood establishment (BE) databases.</p><p><strong>Materials and methods: </strong>An online survey was circulated to the European Blood Alliance's BE-members. The survey collected information on the feasibility of accessing donor data, and challenges and possibilities for linking these datasets with information on the associated blood products and transfusion recipients, and donors' own health records.</p><p><strong>Results: </strong>Seventeen BEs across 16 countries completed the survey. The majority could, in principle, link their donor data to product data (13 BEs, 76%) and recipient data (10 BEs, 59%) for research purposes. However, capabilities were limited and in only 5 of 17 BEs was the donor to recipients' linkage an automated process. BEs reported significant challenges to achieve full vein-to-vein linkage, including legal constraints and lack of consent (11 BEs) and resources (10-14 BEs). Information technology and data issues as well as lack of knowledge and training were cited as obstacles by a minority of BEs.</p><p><strong>Conclusion: </strong>Whilst the survey results suggest considerable interest in developing linkages between blood donors, their products and recipients, many challenges remain due to a variety of obstacles. First steps in working towards a PETRA may be assistance to navigate legal frameworks as well as investing in resources and quality and harmonization of data collections.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70340","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: The 'Pan-European Transfusion Research InfrAstructure' (PETRA) project was established to advance the use of donor, blood product and patient datasets in Europe, aiming to benefit both patient and donor health. Here, the initial PETRA objective was to describe the landscape of existing donor and blood establishment (BE) databases.

Materials and methods: An online survey was circulated to the European Blood Alliance's BE-members. The survey collected information on the feasibility of accessing donor data, and challenges and possibilities for linking these datasets with information on the associated blood products and transfusion recipients, and donors' own health records.

Results: Seventeen BEs across 16 countries completed the survey. The majority could, in principle, link their donor data to product data (13 BEs, 76%) and recipient data (10 BEs, 59%) for research purposes. However, capabilities were limited and in only 5 of 17 BEs was the donor to recipients' linkage an automated process. BEs reported significant challenges to achieve full vein-to-vein linkage, including legal constraints and lack of consent (11 BEs) and resources (10-14 BEs). Information technology and data issues as well as lack of knowledge and training were cited as obstacles by a minority of BEs.

Conclusion: Whilst the survey results suggest considerable interest in developing linkages between blood donors, their products and recipients, many challenges remain due to a variety of obstacles. First steps in working towards a PETRA may be assistance to navigate legal frameworks as well as investing in resources and quality and harmonization of data collections.

从血液机构的角度来看,静脉到静脉数据集的机会:迈向“泛欧洲输血研究基础设施”。
背景和目标:“泛欧输血研究基础设施”(PETRA)项目的建立是为了促进欧洲献血者、血液制品和患者数据集的使用,旨在使患者和献血者的健康都受益。在这里,最初的PETRA目标是描述现有献血者和血液机构(BE)数据库的景观。材料和方法:一份在线调查被分发给欧洲血液联盟的be成员。调查收集了关于获取献血者数据的可行性的信息,以及将这些数据集与有关血液制品和输血接受者的信息以及献血者自身健康记录的信息联系起来的挑战和可能性的信息。结果:来自16个国家的17家银行完成了调查。原则上,大多数人可以将他们的捐赠者数据与产品数据(13个BEs, 76%)和接受者数据(10个BEs, 59%)联系起来用于研究目的。然而,能力是有限的,在17个BEs中,只有5个是供体与受者的联系是一个自动化的过程。be报告了实现静脉到静脉全连接的重大挑战,包括法律限制和缺乏同意(11个be)和资源(10-14个be)。少数BEs认为信息技术和数据问题以及缺乏知识和培训是障碍。结论:虽然调查结果表明,人们对发展献血者、其产品和接受者之间的联系非常感兴趣,但由于各种障碍,仍然存在许多挑战。朝着PETRA努力的第一步可能是协助驾驭法律框架,以及投资于资源、质量和数据收集的统一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书